ICON Public (NASDAQ:ICLR – Get Free Report) had its price target reduced by equities researchers at JPMorgan Chase & Co. from $280.00 to $265.00 in a research note issued on Monday,Benzinga reports.

Earnings Call Transcript January 30, 2025 Sanofi misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were ...

Piper Sandler restated their neutral rating on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a research report ...

The 10 greatest British players of the 2000s have been named including multiple members of England's golden generation.

Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, Kampala, a top health official said Sunday. A range ...

Withings – a French digital health company best-known for its high-tech bathroom scales and blood pressure monitors – ...

Truveta delivers the most representative, complete, and timely patient journey data, exceeding FDA standards of data quality, data provenance, and audit readiness. With EHR data from more than 120 ...

VCS’s innovative and custom-tailored testing services offer specialized cosmetic clinical testing while helping to provide ...

Models built by using artificial intelligence (AI) to annotate clinical reports from more than ... are frequently siloed or stored in free-text notes, thus requiring manual curation to extract ...

In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against other AI news and ratings too important to miss. Artificial intelligence is rapidly ...

ICON Public Limited Company (NASDAQ:ICLR) provides outsourced clinical research and commercialization services, supporting all stages of clinical development for pharmaceutical, biotechnology ...

ICON Public Limited Company (NASDAQ:ICLR) provides outsourced clinical research and commercialization services, supporting all stages of clinical development for pharmaceutical, biotechnology, and ...